Articles

Some CML Patients Can Safely Discontinue Imatinib, Study Suggests

Patients with chronic myeloid leukemia (CML) who have maintained complete molecular remission (CMR) for at least 2 years can safely discontinue imatinib therapy, French researchers report.

TOP - Daily

Many patients diagnosed with skin cancer do not know whether they have melanoma or nonmelanoma skin cancer and, as a result, may have a poor sense of the measures they need to take to reduce the risk of future skin cancers, a

TOP - Daily

In a long-term study of men who underwent robot-assisted radical prostatectomy (RARP) nearly 87% had no recurrence of the disease after 5 years.

The study cohort included 1384 men who were diagnosed with moderately aggressive localized prostate cancer and underwent RARP between September 2001 and May 2005 at a tertiary center. Their average age was 60 years.

TOP - Daily

Researchers identified an association between type 2 diabetes and colorectal cancer (CRC) among men. The association did not hold for women. The new study, published in the October issue of Gastroenterology, found that the risk existed regardless of insulin use. Insulin use, in fact, was found to be associated with a slight but not substantially increased risk of CRC.

TOP - Daily

Use of hospice care for men with prostate cancer has increased significantly over the past 2 decades, but most wait too long to enroll, when they cannot take full advantage of the palliative care services offered, researchers at UCLA's Jonsson Comprehensive Cancer Center have found.

By Arash Asher, MD

September 2010, Vol 3, No 6

Americans afflicted with cancer are living longer, and the outlook for them continues to improve. On the strength of public awareness, early detection, and improved multimodal cancer treatment, cancer has evolved for many patients from an often fatal disease to a chronic, treatable condition. Read More ›

Arash Asher, MD

The Cancer Survivorship Movement: From Idealism to Reality

By Susan Leigh, BSN, RN

September 2010, Vol 3, No 6

Over the past three decades, there has been a gradual yet steady increase in survivorship awareness, resources, and services. Although none of this has happened easily or rapidly, there is no doubt that the concept of cancer survivorship is here to stay. Read More ›

Susan Leigh, BSN, RN

Making Survivorship Care a Priority

By Denice Economou, RN, MN, CNS, AOCN

September 2010, Vol 3, No 6

A recent editorial in the Annals of Internal Medicine states, “If survivorship is a priority, we can improve the lives of survivors.”¹ Increasing recognition of the importance of making survivorship care a priority was the motivating factor for this issue dedicated to cancer survivorship.

Denice Economou, RN, MN, CNS, AOCN

Why Intimacy and Sexuality Matter and What You Can Do to Help Your Patients

By Darja Brandenburg, DClinPsych, DipPST, CPsychol, AFBPS

September 2010, Vol 3, No 6

Difficulties with intimacy and sexuality are among the most common and longest lasting side effects of cancer treatments and can be caused by any of the cancer treatments currently available.¹ Fortunately, even simple recommendations can go a long way toward ameliorating distress for most patients and their partners.^2,3 Yet

A Model of Survivorship Care: The Memorial Sloan-Kettering Approach

September 2010, Vol 3, No 6

In 2005, the Institute of Medicine (IOM) published the report From Cancer Patient to Cancer Survivor: Lost in Transition that recognized survivorship as a distinct phase of the cancer care trajectory, beginning with diagnosis and extending beyond active cancer treatment through follow-up and long-term survival.¹ The report defined optimal care after cancer treatment and offered models and strategies for meeting the long-term needs of Read More ›

Articles

Page 272 of 288